Trials / Sponsors / Graybug Vision
Graybug Vision
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD Neovascular Age-Related Macular Degeneration | Phase 2 | 2019-09-26 |
| Completed | A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occl Diabetic Macular Edema, Retina Vein Occlusion | Phase 2 | 2019-09-11 |
| Completed | A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degene Neovascular Age-Related Macular Degeneration | Phase 1 | 2017-08-29 |